Evidence map›Paper›PMID 35515769›Full record

ReviewRSC advances2020

A review on tetracycline removal from aqueous systems by advanced treatment techniques.

Geetha Gopal, Sruthi Ann Alex, N Chandrasekaran, Amitava Mukherjee

Abstract readReview
In one paragraph

Review in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Green and Economical Synthesis of BiMaterials (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Identification and characterization ofJournal of water and health · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. BioinspiredACS omega · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Geetha GopalCentre for Nanobiotechnology, VIT Vellore 632014 Tamil Nadu India amit.mookerjea@gmail.com amitav@vit.ac.in +91 416 220 2620.
Sruthi Ann AlexCentre for Nano Science and Technology, Anna University Chennai India.
N ChandrasekaranCentre for Nanobiotechnology, VIT Vellore 632014 Tamil Nadu India amit.mookerjea@gmail.com amitav@vit.ac.in +91 416 220 2620.ORCID https://orcid.org/0000-0002-0586-134X
Amitava MukherjeeCentre for Nanobiotechnology, VIT Vellore 632014 Tamil Nadu India amit.mookerjea@gmail.com amitav@vit.ac.in +91 416 220 2620.ORCID https://orcid.org/0000-0001-8682-4278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetracycline (TC), a frequently used drug for human and veterinary therapeutics, is among the most common antibiotic residues found in nature. Lack of advanced treatment techniques in the wastewater treatment plants (WWTPs) to remove residual TC from domestic and hospital wastewater poses a serious environmental risk. It is important to have an insight into the different advanced treatment techniques for efficient removal of TC from the surface water and in the WWTPs. The aim of this review is to discuss the nature and occurrence of TC in surface water and to present an overview of the various advanced treatment techniques for TC removal. The advanced treatment techniques include advanced oxidation processes (photolysis, ozonation, and catalytic/UV light-based degradation), membrane filtration, reverse osmosis, and adsorption techniques. Adsorption and integrated oxidation treatment techniques are the most widely studied methods, and they are widely accepted because of less cost, reusability, and toxic-free nature. Further, the uses of various types of catalysts for photodegradation and various sorbents for adsorption of TC are also presented. Finally, the importance of green nanocomposite for environmental sustainability in TC removal is emphasized.

Identifiers

PMID35515769
PMCPMC9055545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.